S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
NASDAQ:SSKN

STRATA Skin Sciences - SSKN Stock Forecast, Price & News

$0.98
-0.02 (-1.99%)
(As of 08/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.98
$1.01
50-Day Range
$0.93
$1.18
52-Week Range
$0.92
$1.95
Volume
65,938 shs
Average Volume
53,678 shs
Market Capitalization
$34.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

STRATA Skin Sciences MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.31% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.16mentions of STRATA Skin Sciences in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$1,092 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.23) to ($0.12) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.43 out of 5 stars

Medical Sector

1077th out of 1,116 stocks

Surgical & Medical Instruments Industry

107th out of 112 stocks

SSKN stock logo

About STRATA Skin Sciences (NASDAQ:SSKN) Stock

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

STRATA Skin Sciences Price Performance

Shares of NASDAQ:SSKN opened at $1.00 on Friday. STRATA Skin Sciences has a twelve month low of $0.92 and a twelve month high of $1.95. The company has a current ratio of 1.30, a quick ratio of 0.96 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $34.72 million, a price-to-earnings ratio of -6.25 and a beta of 1.89. The firm has a 50-day moving average of $1.05 and a two-hundred day moving average of $1.26.

Receive SSKN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

SSKN Stock News Headlines

Strata Skin Sciences Earnings Preview
STRATA Skin Sciences Q4 2021 Earnings Preview
Earnings Outlook For Strata Skin Sciences
See More Headlines
Receive SSKN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

SSKN Company Calendar

Last Earnings
11/10/2021
Today
8/19/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SSKN
Employees
115
Year Founded
N/A

Profitability

Net Income
$-2,710,000.00
Pretax Margin
-17.41%

Debt

Sales & Book Value

Annual Sales
$29.98 million
Book Value
$0.64 per share

Miscellaneous

Free Float
20,684,000
Market Cap
$34.17 million
Optionable
Not Optionable
Beta
1.89

Social Links


Key Executives

  • Mr. William D. Humphries (Age 56)
    Exec. Chairman
    Comp: $70.58k
  • Mr. Robert J. Moccia (Age 63)
    Pres, CEO & Director
    Comp: $818.1k
  • Mr. Christopher Lesovitz (Age 40)
    Chief Financial Officer
    Comp: $527.12k
  • Mr. Jay Sturm (Age 66)
    Gen. Counsel & Corp. Sec.
  • Keith Simeone
    VP of Sales
  • Dr. Darrell S. Rigel (Age 71)
    Chief Medical Advisor
  • Mr. Shmuel Gov
    Exec. VP & GM
  • Mr. Michael E. Goodman
    Head of International Sales
  • Mr. Nikolai Kabelev (Age 46)
    VP of R&D
  • Mr. Michael R. Stewart (Age 65)
    Independent Consultant













SSKN Stock - Frequently Asked Questions

How have SSKN shares performed in 2022?

STRATA Skin Sciences' stock was trading at $1.4650 at the beginning of 2022. Since then, SSKN stock has decreased by 31.7% and is now trading at $1.00.
View the best growth stocks for 2022 here
.

When is STRATA Skin Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our SSKN earnings forecast
.

How were STRATA Skin Sciences' earnings last quarter?

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) posted its earnings results on Wednesday, November, 10th. The medical device company reported ($0.02) EPS for the quarter, topping analysts' consensus estimates of ($0.05) by $0.03. The medical device company had revenue of $7.71 million for the quarter, compared to analysts' expectations of $7.78 million. STRATA Skin Sciences had a negative net margin of 17.34% and a negative trailing twelve-month return on equity of 23.39%. During the same quarter last year, the business posted ($0.04) earnings per share.

When did STRATA Skin Sciences' stock split?

STRATA Skin Sciences's stock reverse split on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 9th 2014. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What guidance has STRATA Skin Sciences issued on next quarter's earnings?

STRATA Skin Sciences issued an update on its FY 2022 earnings guidance on Friday, August, 19th. The company provided EPS guidance of for the period. The company issued revenue guidance of $33.00 million-$35.00 million, compared to the consensus revenue estimate of $34.15 million.

What other stocks do shareholders of STRATA Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Trevena (TRVN), Amarin (AMRN), Biocept (BIOC), Kopin (KOPN), OPKO Health (OPK), Plug Power (PLUG), AbbVie (ABBV), SCYNEXIS (SCYX), Tonix Pharmaceuticals (TNXP) and Agile Therapeutics (AGRX).

What is STRATA Skin Sciences' stock symbol?

STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."

Who are STRATA Skin Sciences' major shareholders?

STRATA Skin Sciences' stock is owned by a variety of institutional and retail investors. Top institutional investors include Western Standard LLC (3.27%) and FNY Investment Advisers LLC (0.15%). Insiders that own company stock include Christopher Lesovitz, Luann Via, Robert Joseph Moccia, Samuel Rubinstein and William D Humphries.
View institutional ownership trends
.

How do I buy shares of STRATA Skin Sciences?

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STRATA Skin Sciences' stock price today?

One share of SSKN stock can currently be purchased for approximately $1.00.

How much money does STRATA Skin Sciences make?

STRATA Skin Sciences (NASDAQ:SSKN) has a market capitalization of $34.72 million and generates $29.98 million in revenue each year. The medical device company earns $-2,710,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis.

How many employees does STRATA Skin Sciences have?

The company employs 115 workers across the globe.

How can I contact STRATA Skin Sciences?

STRATA Skin Sciences' mailing address is 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044. The official website for the company is www.strataskinsciences.com. The medical device company can be reached via phone at (215) 619-3200, via email at bob@lifesciadvisors.com, or via fax at 215-619-3208.

This page (NASDAQ:SSKN) was last updated on 8/19/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.